Loading…
InspireMD, Inc. is projected to decline to $0.6456 by 2027, a -5% move from its current price of $0.681. NSPR is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.6657 | $0.681 | $0.6967 | 0.00% |
| Aug 6 | $0.6594 | $0.681 | $0.7033 | 0.00% |
| Aug 7 | $0.6547 | $0.681 | $0.7084 | 0.00% |
| Aug 8 | $0.6507 | $0.681 | $0.7127 | 0.00% |
| Aug 9 | $0.6472 | $0.681 | $0.7166 | 0.00% |
| Aug 10 | $0.6441 | $0.681 | $0.7201 | 0.00% |
| Aug 11 | $0.6412 | $0.681 | $0.7233 | +0.01% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.6412 | $0.681 | $0.7233 | +0.01% |
| Week 2 | $0.6255 | $0.6811 | $0.7416 | +0.01% |
| Week 3 | $0.6137 | $0.6811 | $0.756 | +0.02% |
| Week 4 | $0.6039 | $0.6811 | $0.7683 | +0.02% |
| Week 5 | $0.5954 | $0.6812 | $0.7793 | +0.03% |
| Week 6 | $0.5878 | $0.6812 | $0.7895 | +0.03% |
| Week 7 | $0.5809 | $0.6812 | $0.7989 | +0.04% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
InspireMD, Inc. is a medical device company focused on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Carotid Stent System; and SwitchGuard neuroprotection system to provide flow reversal of cerebral protection in carotid interventions, as well as treating acute stroke with tandem lesions.
The company was founded in 2005 and is headquartered in Miami, Florida.
InspireMD trades under the symbol NSPR and has a current price of $0.6895 with a market capitalization of $32.3M and a market rank of 4542. The near‑term picture sits in neutral territory as shown by a neutral sentiment and a 14‑day RSI of 40. The current price action is framed by a 50‑day simple moving average at $0.8094 and a 200‑day simple moving average at $1.53, with defined support at $0.66 and resistance at $0.76.
The 30‑day trading range spans from $0.584 to $0.814.
A major floor 11.4% below — a decisive break under it would weaken the trend.
The nearest floor, 4.6% below — buyers have tended to step in here.
The nearest ceiling, 5.7% above — a clean break opens room to run.
A major ceiling 162.8% above — clearing it would confirm fresh momentum.
Key NSPR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NSPR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.672 | Buy | $0.6686 | Buy |
| MA 10 | $0.683 | Sell | $0.6796 | Buy |
| MA 20 | $0.6975 | Sell | $0.6974 | Sell |
| MA 50 | $0.7682 | Sell | $0.8084 | Sell |
| MA 100 | $1.08 | Sell | $1.04 | Sell |
| MA 200 | $1.48 | Sell | $1.39 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 31.16 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -197.92 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | -9.72 | Sell |
| Bollinger %B (20,2) | -0.11 | Buy |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.58 | Sell |
| Awesome (5,34) | -0.03 | Sell |
| Ultimate (7,14,28) | 17.20 | Buy |
| Momentum (10) | -0.05 | Sell |
| Aroon Osc (25) | -48.00 | Sell |
| Hull MA (9) | 0.66 | Buy |
| ADX (14) | 27.57 | Sell |
| ATR (14) | 0.01 | Info |
Near term the setup remains NEUTRAL, with RSI14 at 40 indicating modest momentum. The 50‑day moving average stands at $0.8094 while the 200‑day moving average is at $1.53, highlighting potential resistance above the current price. Support is cited at $0.66 and resistance at $0.76, framing a 30‑day range from $0.584 to $0.814.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.65 | $0.681 | $0.8116 | 0% | Neutral | |
| $0.5227 | $0.6456 | $0.8377 | -5% | Neutral | |
| $0.5345 | $0.6756 | $0.9053 | -1% | Neutral | |
| $0.5672 | $0.7307 | $1.00 | +7% | Neutral | |
| $0.5992 | $0.7848 | $1.10 | +15% | Neutral | |
| $0.626 | $0.8325 | $1.19 | +22% | Bullish | |
| $0.5965 | $0.8044 | $1.17 | +18% | Neutral | |
| $0.5851 | $0.7995 | $1.18 | +17% | Neutral | |
| $0.5878 | $0.8132 | $1.22 | +19% | Neutral | |
| $0.5991 | $0.8387 | $1.27 | +23% | Bullish | |
| $0.7393 | $1.09 | $1.75 | +60% | Bullish | |
| $1.28 | $2.07 | $3.59 | +204% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.65 | $0.681 | $0.7953 | +0.00% |
| September 2026 | $0.5714 | $0.6723 | $0.8109 | -1.27% |
| October 2026 | $0.5758 | $0.6815 | $0.8294 | +1.36% |
| November 2026 | $0.5605 | $0.6664 | $0.8171 | -2.20% |
| December 2026 | $0.5507 | $0.6575 | $0.8116 | -1.34% |
Click any year to see its month-by-month NSPR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, NSPR is projected to trade between $0.65 and $0.8116, averaging $0.681 — a potential gain of 0% from today's $0.681. Price action looks broadly range-bound.
InspireMD, Inc.'s 2027 outlook centres on $0.6456, within a $0.5227 to $0.8377 range. That is -5% versus the projected 2026 average. That marks a -5% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, NSPR could reach as high as $0.9053, with a base case around $0.6756 and support toward $0.5345 — roughly -1% from $0.681. Price action looks broadly range-bound.
Expect NSPR to range from $0.5672 to $1.00 through 2029. The $0.7307 average target implies a +7% move from current prices. That is up +8% on the projected 2028 average. A consolidation phase looks the most probable path here.
The NSPR price prediction for 2030 points to an average of $0.7848 (low $0.5992, high $1.10) — a potential gain of +15% on today's $0.681. Price action looks broadly range-bound.
In 2031, NSPR is projected to trade between $0.626 and $1.19, averaging $0.8325 — a potential gain of +22% from today's $0.681. That is up +6% on the projected 2030 average. Buyers look set to stay in control over this stretch.
InspireMD, Inc.'s 2032 outlook centres on $0.8044, within a $0.5965 to $1.17 range. That is -3% versus the projected 2031 average. That marks a +18% change versus current levels. Price action looks broadly range-bound.
By 2033, NSPR could reach as high as $1.18, with a base case around $0.7995 and support toward $0.5851 — roughly +17% from $0.681. A consolidation phase looks the most probable path here.
Expect NSPR to range from $0.5878 to $1.22 through 2034. The $0.8132 average target implies a +19% move from current prices. That is up +2% on the projected 2033 average. Price action looks broadly range-bound.
The NSPR price prediction for 2035 points to an average of $0.8387 (low $0.5991, high $1.27) — a potential gain of +23% on today's $0.681. Buyers look set to stay in control over this stretch.
In 2040, NSPR is projected to trade between $0.7393 and $1.75, averaging $1.09 — a potential gain of +60% from today's $0.681. That is up +30% on the projected 2035 average. Momentum favours further upside here.
InspireMD, Inc.'s 2050 outlook centres on $2.07, within a $1.28 to $3.59 range. That is up +90% on the projected 2040 average. That marks a +204% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in NSPR today (≈ 1,468.428781 NSPR) could be worth
$3,042.25
+$2,042.25 (+204%) by 2050 · US Dollar
Based on the average projected NSPR price of $2.07 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NSPRwould be worth at today's price.
$1,000 invested in NSPR on Jul 31, 2025 (≈ 358.422944 NSPR) would be worth
$244.09
-$755.91 (-75.6%) today · 0.24× · US Dollar
Based on a NSPR entry price of $2.79 vs. today's $0.681.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.68 | $1,001.47 | +0.1% |
| 1 month ago | $0.68 | $1,001.47 | +0.1% |
| 3 months ago | $1.15 | $592.17 | -40.8% |
| 6 months ago | $1.63 | $417.79 | -58.2% |
| 1 year ago | $2.79 | $244.09 | -75.6% |
| All time (5.0y) ago | $3.84 | $177.34 | -82.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NSPR forecast.
Our base-case forecast reaches $1.40 around 2050.
Implied market cap at $1.40: $65.57M
The multi‑year forecast lays out gradual upside with a sequence of higher average prices and positive returns in several years. In 2026 the avg is $0.6895, with a max of $0.8281 and a min of $0.66 (ROI 0, sentiment NEUTRAL). By 2029 the max reaches $1.05 and the average climbs to $0.7526 (ROI 9.2).
The 2030 forecast shows an avg of $0.8048 with a max of $1.15 (ROI 16.7) and sentiment NEUTRAL, followed by 2031 with avg $0.845 and max $1.23 (ROI 22.6, sentiment BULLISH). The path extends to 2035 with avg $0.8601 and max $1.34 (ROI 24.8, sentiment BULLISH), 2040 with avg $1.09 and max $1.80 (ROI 58.6, sentiment BULLISH), and 2050 with avg $2.14 and max $3.83 (ROI 209.8, sentiment BULLISH). The forecast thus envisions a rising trajectory over the long run, but also includes years with modest or negative short‑term returns (e.g., 2027 ROI −5.2 and 2028 ROI −1.5).
Tap a question to reveal the answer.
In 2030 the forecast shows min $0.605, avg $0.8048, max $1.15 with ROI 16.7 and sentiment NEUTRAL.
The forecast shows a mixed path: some years produce positive ROI (e.g., 2029 ROI 9.2, 2030 ROI 16.7, 2031 ROI 22.6, 2050 ROI 209.8) while others are negative (e.g., 2027 ROI −5.2, 2028 ROI −1.5). Current price is $0.6895, and outcomes vary by year.
Yes. The forecasted max for 2029 is $1.05 and for 2030 is $1.15.
Current price is $0.6895 with neutral sentiment. RSI14 is 40, the SMA50 is $0.8094 and the SMA200 is $1.53. Support sits at $0.66 and resistance at $0.76, with a 30‑day range from $0.584 to $0.814.
Current price: $0.6895. Market cap: $32.3M. Rank: 4542.
InspireMD, Inc. Community Discussion
0Share your InspireMD, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.